In patients with rheumatoid arthritis, anti-TNF-αtherapies could reduce the progression of atherosclerosis, indicating that thepathogenesis of atherosclerosis involves shared TNFα/ROS inflammatorypathways at the crossing between Loop 1 and 2 [58]. This evidence concerns the gene TNF and atherosclerosis.